Literature DB >> 184329

Mouse hepatitis virus (MHV-2). Plaque assay and propagation in mouse cell line DBT cells.

N Hirano, K Fujiwara, M Matumoto.   

Abstract

Various factor sinfluencing the plaque formation of mouse hepatitis virus (MHV-2) in DBT cell monolayers were studied and a practical method for plaque assay was developed. Infected DBT cells yielded high-titered virus and were a satisfactory source of complement-fixing viral antigen. The predominant cytopathic effect of MHV-2 in DBT cells was cell rounding and detachment, but no syncytial formation was observed. Fluorescent antibody staining revealed specific fluorescence only in the cytoplasm of infected DBT cells. In one-step growth experiment, newly formed virus was first recognized within 4-hr postinfection and showed subsequently a rapid exponential increase. Release of newly formed virus from the cell was rapid, and a continuous release lasted for a certain period of time. The average per-cell yield of active virus was estimated to be about 6-7 X 10(2) plaque-forming units.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184329

Source DB:  PubMed          Journal:  Jpn J Microbiol        ISSN: 0021-5139


  44 in total

Review 1.  Viral mutation rates.

Authors:  Rafael Sanjuán; Miguel R Nebot; Nicola Chirico; Louis M Mansky; Robert Belshaw
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

2.  Replication of murine hepatitis virus is regulated by papain-like proteinase 1 processing of nonstructural proteins 1, 2, and 3.

Authors:  Rachel L Graham; Mark R Denison
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells.

Authors:  S A Stohlman; L P Weiner
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

4.  Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes.

Authors:  A C Sims; J Ostermann; M R Denison
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Reselection of a genomic upstream open reading frame in mouse hepatitis coronavirus 5'-untranslated-region mutants.

Authors:  Hung-Yi Wu; Bo-Jhih Guan; Yu-Pin Su; Yi-Hsin Fan; David A Brian
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

6.  Sequence of 2,617 nucleotides from the 3' end of Newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein.

Authors:  N Ishida; H Taira; T Omata; K Mizumoto; S Hattori; K Iwasaki; M Kawakita
Journal:  Nucleic Acids Res       Date:  1986-08-26       Impact factor: 16.971

7.  Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase.

Authors:  Sarah M Brockway; Corrie T Clay; Xiao Tao Lu; Mark R Denison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  A novel mutation in murine hepatitis virus nsp5, the viral 3C-like proteinase, causes temperature-sensitive defects in viral growth and protein processing.

Authors:  Jennifer S Sparks; Eric F Donaldson; Xiaotao Lu; Ralph S Baric; Mark R Denison
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Authors:  Shin-Ichiro Kawamoto; Kenji Oritani; Hideo Asada; Isao Takahashi; Jun Ishikawa; Hitoshi Yoshida; Masahide Yamada; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replication.

Authors:  Mark R Denison; Boyd Yount; Sarah M Brockway; Rachel L Graham; Amy C Sims; XiaoTao Lu; Ralph S Baric
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.